Evidence map›Paper›PMID 25948735›Full record

ArticleAmerican journal of physiology. Cell physiology2015

Tumor necrosis factor-α induces a biphasic change in claudin-2 expression in tubular epithelial cells: role in barrier functions.

Yasaman Amoozadeh, Qinghong Dan, Jenny Xiao, Faiza Waheed, Katalin Szászi

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Claudin-2 Mediates the Proximal Tubular Epithelial Cell-Fibroblast Crosstalk via Paracrine CTGF.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  6. The role of claudins in homeostasis.Nature reviews. Nephrology · 2023
    Review
  7. Digested Cinnamon (International journal of molecular sciences · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Anti-Obesity Effect ofFrontiers in endocrinology · 2020
    Article
  19. Claudin-2: Roles beyond Permeability Functions.International journal of molecular sciences · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yasaman AmoozadehKeenan Research Centre for Biomedical Science of the St. Michael's Hospital and Department of Surgery, University of Toronto, Ontario, Canada.
Qinghong DanKeenan Research Centre for Biomedical Science of the St. Michael's Hospital and Department of Surgery, University of Toronto, Ontario, Canada.
Jenny XiaoKeenan Research Centre for Biomedical Science of the St. Michael's Hospital and Department of Surgery, University of Toronto, Ontario, Canada.
Faiza WaheedKeenan Research Centre for Biomedical Science of the St. Michael's Hospital and Department of Surgery, University of Toronto, Ontario, Canada.
Katalin SzásziKeenan Research Centre for Biomedical Science of the St. Michael's Hospital and Department of Surgery, University of Toronto, Ontario, Canada szaszik@smh.ca.
University of Toronto · CASt. Michael's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inflammatory cytokine tumor necrosis factor-α (TNF-α) is a pathogenic factor in acute and chronic kidney disease. TNF-α is known to alter expression of epithelial tight junction (TJ) proteins; however, the underlying mechanisms and the impact of this effect on epithelial functions remain poorly defined. Here we describe a novel biphasic effect of TNF-α on TJ protein expression. In LLC-PK1 tubular cells, short-term (1-6 h) TNF-α treatment selectively elevated the expression of the channel-forming TJ protein claudin-2. In contrast, prolonged (>8 h) TNF-α treatment caused a marked downregulation in claudin-2 and an increase in claudin-1, -4, and -7. The early increase and the late decrease in claudin-2 expression involved distinct mechanisms. TNF-α slowed claudin-2 degradation through ERK, causing the early increase. This increase was also mediated by the EGF receptor and RhoA and Rho kinase. In contrast, prolonged TNF-α treatment reduced claudin-2 mRNA levels and promoter activity independent from these signaling pathways. Electric Cell-substrate Impedance Sensing measurements revealed that TNF-α also exerted a biphasic effect on transepithelial resistance (TER) with an initial decrease and a late increase. Thus there was a good temporal correlation between TNF-α-induced claudin-2 protein and TER changes. Indeed, silencing experiments showed that the late TER increase was at least in part caused by reduced claudin-2 expression. Surprisingly, however, claudin-2 silencing did not prevent the early TER drop. Taken together, the TNF-α-induced changes in claudin-2 levels might contribute to TER changes and could also play a role in newly described functions of claudin-2 such as proliferation regulation.

Indexed as

AnimalsClaudinsElectric ImpedanceEpithelial CellsErbB ReceptorsExtracellular Signal-Regulated MAP KinasesGene Expression RegulationHT29 CellsHumansKidney Tubules, ProximalLLC-PK1 CellsPermeabilityProteolysisrhoA GTP-Binding Proteinrho-Associated KinasesRNA InterferenceClaudinsCLDN2 protein, humanEGFR protein, mouseErbB ReceptorsExtracellular Signal-Regulated MAP KinasesrhoA GTP-Binding ProteinRHOA protein, humanrho-Associated KinasesRNA, MessengerTumor Necrosis Factor-alphaECIStight junctiontransepithelial resistancetubular epithelial cellstumor necrosis factor

Identifiers

PMID25948735
PMCPMC4490324
OpenAlexW1903513044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.